Search hospitals > North Carolina > Burlington
Cone Health Cancer Center at Alamance Regional
Claim this profileBurlington, North Carolina 27215
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Ovarian Cancer
107 reported clinical trials
1 medical researcher
Summary
Cone Health Cancer Center at Alamance Regional is a medical facility located in Burlington, North Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Ovarian Cancer and other specialties. Cone Health Cancer Center at Alamance Regional is involved with conducting 107 clinical trials across 142 conditions. There are 1 research doctors associated with this hospital, such as Vinay K. Gudena.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Clinical Trials running at Cone Health Cancer Center at Alamance Regional
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Squamous Cell Carcinoma
ALK Gene Rearrangement
Cognitive Impairment
Recurrence
Blood Cancers
Tumors
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cone Health Cancer Center at Alamance Regional?
Cone Health Cancer Center at Alamance Regional is a medical facility located in Burlington, North Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Ovarian Cancer and other specialties. Cone Health Cancer Center at Alamance Regional is involved with conducting 107 clinical trials across 142 conditions. There are 1 research doctors associated with this hospital, such as Vinay K. Gudena.